479 related articles for article (PubMed ID: 14638887)
1. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
[TBL] [Abstract][Full Text] [Related]
2. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
3. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
5. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
[TBL] [Abstract][Full Text] [Related]
6. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
8. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
Martínez-Rodríguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J
Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240
[TBL] [Abstract][Full Text] [Related]
10. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
11. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
[TBL] [Abstract][Full Text] [Related]
12. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
13. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
15. CSF hypocretin-1 assessment in sleep and neurological disorders.
Bourgin P; Zeitzer JM; Mignot E
Lancet Neurol; 2008 Jul; 7(7):649-62. PubMed ID: 18565458
[TBL] [Abstract][Full Text] [Related]
16. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis.
Oka Y; Kanbayashi T; Mezaki T; Iseki K; Matsubayashi J; Murakami G; Matsui M; Shimizu T; Shibasaki H
J Neurol; 2004 Jul; 251(7):885-6. PubMed ID: 15258796
[No Abstract] [Full Text] [Related]
17. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
18. Presentations of primary hypersomnia in Chinese children.
Han F; Lin L; Li J; Aran A; Dong SX; An P; Zhao L; Li M; Li QY; Yan H; Wang JS; Gao HY; Li M; Gao ZC; Strohl KP; Mignot E
Sleep; 2011 May; 34(5):627-32. PubMed ID: 21532956
[TBL] [Abstract][Full Text] [Related]
19. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions.
Dauvilliers Y; Delallée N; Jaussent I; Scholz S; Bayard S; Croyal M; Schwartz JC; Robert P
Sleep; 2012 Oct; 35(10):1359-66. PubMed ID: 23024434
[TBL] [Abstract][Full Text] [Related]
20. Melanin concentrating hormone in central hypersomnia.
Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
